This company is a leading pharmaceutical manufacturer with over 30 years of experience. They produce a range of prescription medications and over-the-counter drugs across several therapeutic areas, including cardiology and angiology, infectious diseases, metabolism and nutrition. They hold numerous marketing authorizations (AMMs) and have developed key products such as CP 250 mg BTE10, Afucid cream, Cotazar 80/12.5 mg B30, and Redulip 40 mg. The company operates in the EU and North America, demonstrating international reach and partnerships. Their commitment to quality is evidenced by GMP certifications.

This CTD dossier owner and manufacturer was established in the 1950s, quality is the main focus of continuous quality improvement programs and extensive efforts to pursue perfection. Throughout the half-century, recognition has been gained from multinational companies all over the world. The company follows straight of the PIC/S GMP standard, starting from raw material quality inspection, and in-process quality control to end product quality assurance, complete sets of quality records are kept for analysis and future reference.

Established in 2011, this CTD dossier owner and manufacturer has grown to become a leading GMP manufacturer, employing over 300 professionals. With GMP approvals in various regions, the manufacturer ensures high-quality standards across its production lines, specializing in solid and liquid dosage forms. Their products are sold in more than 50 countries and regions worldwide, showcasing their global reach as a CTD dossier owner and manufacturer. As a trusted GMP manufacturer, they maintain rigorous compliance to meet international regulations, reinforcing their commitment to quality and excellence in pharmaceutical manufacturing.